Commonwealth Bank of Australia’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Commonwealth Bank of Australia’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-29	Closed	–	–	876
2017 Q4	$0	Hold	29	–	–	﹤0.01%	889
2017 Q3	$0	Sell	29 -3	-9%	-$176	﹤0.01%	890
2017 Q2	$1K	Sell	32 -2,911	-99%	-$166K	﹤0.01%	880
2017 Q1	$160K	Buy	+2,943	New	+$145K	﹤0.01%	629

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Commonwealth Bank of Australia's BIVV Position: Q1 2018 in Review

Commonwealth Bank of Australia sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 29 shares.

Commonwealth Bank of Australia first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $160K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Commonwealth Bank of Australia reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Commonwealth Bank of Australia sold 29 Bioverativ Inc. Common Stock shares in Q1 2018.
Commonwealth Bank of Australia first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Commonwealth Bank of Australia's Bioverativ Inc. Common Stock position peaked at $160K in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Commonwealth Bank of Australia's 13F filing for Q1 2018, filed 14 May 2018.